| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 3 |
| 1 | TACROLIMUS | 3 |
| 2 | CALCIUM | 2 |
| 3 | CINACALCET HYDROCHLORIDE | 2 |
| 4 | LOSARTAN | 2 |
| 5 | OMEPRAZOLE | 2 |
| 6 | OMEPRAZOLE MAGNESIUM | 2 |
| 7 | PARICALCITOL | 2 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 2 |
| 9 | TACROLIMUS OINTMENT 0.1% | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RILONACEPT | 1 | 0.0009 |
| 1 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 2 | LANTHANUM CARBONATE | 1 | 0.0002 |
| 3 | PARICALCITOL | 2 | 0.0001 |
| 4 | FEBUXOSTAT TABLETS 40 MG | 1 | 0.0001 |
| 5 | FEBUXOSTAT | 1 | 0.0001 |
| 6 | ALEMTUZUMAB | 1 | 0.0001 |
| 7 | CALCITRIOL CAPSULES 0.25 MCG | 1 | 0.0000 |
| 8 | CINACALCET HYDROCHLORIDE | 2 | 0.0000 |
| 9 | ZINC CHLORIDE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3 |
| 1 | GLP-1 Receptor Agonist [EPC] | 3 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| 3 | Proton Pump Inhibitor [EPC] | 3 |
| 4 | Calcium [EPC] | 2 |
| 5 | Vitamin D Analog [EPC] | 2 |
| 6 | Vitamin D2 Analog [EPC] | 2 |
| 7 | beta-Adrenergic Blocker [EPC] | 2 |
| 8 | Antirheumatic Agent [EPC] | 1 |
| 9 | Benzodiazepine [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 1 | Vitamin D Analog [EPC] | 2 | 0.0001 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 3 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 6 | Calcium [EPC] | 2 | 0.0000 |
| 7 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 8 | alpha-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 9 | GLP-1 Receptor Agonist [EPC] | 3 | 0.0000 |